Boule Diagnostics competitorsClear all

Boule Diagnostics's top competitors include Owlstone Medical, Bactiguard and CellAegis Devices.

	Boule Diagnostics Boule Diagnostics, a diagnostics company, develops, manufactures, and distributes instruments and consumable products for hematology diagnostics.	Owlstone Medical Owlstone Medical provides medical products and services.	Bactiguard Bactiguard, a medtech company, develops and provides infection prevention solutions.	CellAegis Devices CellAegis Devices offers autoRIC, an automated non-invasive device that provides point-of-care delivery of remote ischemic conditioning.
Founding Date	Founding Date 1956	Founding Date 2004	Founding Date 2005	Founding Date N/A
Type	Type Public	Type Private	Type Public	Type Private
Tags	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Healthcare Technology healthtech medical devices medical diagnostics	Tags Healthcare healthtech medical devices medical diagnostics medtech	Tags Healthcare healthtech medical devices medical diagnostics medtech
Locations	Locations Spånga, SE HQ Moskva, RU Plantation, US	Locations Milton, GB HQ London, GB Milton, GB Westport, US	Locations Botkyrka, SE HQ	Locations HQ Mississauga, CA Palo Alto, US Palo Alto, US
Employees	Employees 21226% increase	Employees 1611% increase	Employees 210	Employees 6
Twitter followers	Twitter followers N/A	Twitter followers 5	Twitter followers 621	Twitter followers N/A
Alexa Website Rank	Alexa Website Rank 312148	Alexa Website Rank 36612	Alexa Website Rank N/A	Alexa Website Rank N/A
Employee Rating	Employee Rating 4	Employee Rating 3.7	Employee Rating 4.5	Employee Rating N/A
Financial
Revenue (est.)	Revenue (est.) kr463.3m (FY, 2021)	Revenue (est.) £2.6m (FY, 2018)	Revenue (est.) kr169.5m (FY, 2021)	Revenue (est.) N/A
Cost of goods	Cost of goods (kr243.3m) (FY, 2021)	Cost of goods £847.6k (FY, 2018)	Cost of goods (kr41.1m) (FY, 2021)	Cost of goods N/A
Gross profit	Gross profit kr228.5m (FY, 2021)	Gross profit £1.8m (FY, 2018)	Gross profit kr134.2m (FY, 2021)	Gross profit N/A
Net income	Net income kr23.3m (FY, 2021)	Net income (£7.9m) (FY, 2018)	Net income (kr58.8m) (FY, 2021)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 35m (over 3 years ago)	Latest funding round N/A	Latest funding round $ 9.5m (about 5 years ago)
Total funding raised	Total funding raised $ 52.9k	Total funding raised $ 66.5m	Total funding raised $ 14.9m	Total funding raised $ 9.5m